Improving accuracy and reproducibility in microRNA-based diagnostics

· Customer Testimonial

Improving accuracy and reproducibility in microRNA-based diagnostics

MiRXES, a biotechnology company based in Singapore, is using ID3EAL™ – an RT-qPCR technology platform – for sensitive, specific and robust detection of microRNAs in biofluids and tissue samples. This technology allows the company to identify microRNA biomarkers, and develop them into new diagnostic kits for the early identification of cancer and infectious diseases. Its research department is using automatic pipetting solutions from INTEGRA – including the VOYAGER, VIAFLO 96, VIAFLO 384 and ASSIST PLUS – to streamline workflows and improve accuracy and reproducibility.

Rate this article

CAPTCHA